Home/Filings/4/0001209191-23-054441
4//SEC Filing

INGRAM DOUGLAS S 4

Accession 0001209191-23-054441

CIK 0000873303other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 8:00 AM ET

Size

11.0 KB

Accession

0001209191-23-054441

Insider Transaction Report

Form 4
Period: 2023-11-03
INGRAM DOUGLAS S
DirectorPresident & CEO
Transactions
  • Purchase

    Common Stock

    2023-11-03$80.33/sh+3,884$312,002390,107 total
  • Purchase

    Common Stock

    2023-11-03$78.57/sh+10,081$792,064375,163 total
  • Purchase

    Common Stock

    2023-11-03$79.70/sh+11,060$881,482386,223 total
  • Purchase

    Common Stock

    2023-11-03$81.26/sh+200$16,252390,307 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.03 to $79.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.05 to $80.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.08 to $80.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0001190644

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:00 AM ET
Size
11.0 KB